US10401275B2 - Analysis method for supporting classification - Google Patents
Analysis method for supporting classification Download PDFInfo
- Publication number
- US10401275B2 US10401275B2 US14/912,876 US201414912876A US10401275B2 US 10401275 B2 US10401275 B2 US 10401275B2 US 201414912876 A US201414912876 A US 201414912876A US 10401275 B2 US10401275 B2 US 10401275B2
- Authority
- US
- United States
- Prior art keywords
- analysis
- classification
- optical
- analysis method
- dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 145
- 230000003287 optical effect Effects 0.000 claims abstract description 124
- 239000006185 dispersion Substances 0.000 claims abstract description 71
- 238000003745 diagnosis Methods 0.000 claims abstract description 34
- 238000012360 testing method Methods 0.000 claims description 40
- 210000004027 cell Anatomy 0.000 claims description 10
- 230000001419 dependent effect Effects 0.000 claims description 8
- 206010061217 Infestation Diseases 0.000 claims description 7
- 230000007812 deficiency Effects 0.000 claims description 7
- 239000002612 dispersion medium Substances 0.000 claims description 7
- 230000003071 parasitic effect Effects 0.000 claims description 7
- 238000004364 calculation method Methods 0.000 claims description 5
- 230000006978 adaptation Effects 0.000 claims description 4
- 210000003850 cellular structure Anatomy 0.000 claims description 4
- 238000011156 evaluation Methods 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 230000003595 spectral effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 239000011368 organic material Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 208000004554 Leishmaniasis Diseases 0.000 claims description 2
- 208000007502 anemia Diseases 0.000 claims description 2
- 208000005980 beta thalassemia Diseases 0.000 claims description 2
- 208000022806 beta-thalassemia major Diseases 0.000 claims description 2
- 208000007056 sickle cell anemia Diseases 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 15
- 238000004590 computer program Methods 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009826 distribution Methods 0.000 description 31
- 210000003743 erythrocyte Anatomy 0.000 description 22
- 201000004792 malaria Diseases 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000001772 blood platelet Anatomy 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 9
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 230000002489 hematologic effect Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 4
- 238000004204 optical analysis method Methods 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000491 multivariate analysis Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 238000012952 Resampling Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G01N2015/0073—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1477—Multiparameters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1488—Methods for deciding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1497—Particle shape
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N2021/4702—Global scatter; Total scatter, excluding reflections
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
- G01N2021/4764—Special kinds of physical applications
- G01N2021/4769—Fluid samples, e.g. slurries, granulates; Compressible powdery of fibrous samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Definitions
- the invention relates to an analysis method for classification assistance, an ascertainment method for determining parameters of the analysis method, and a computer program product, as well as an optical analysis system.
- optical analysis systems and optical methods are used to optically analyze organic dispersions, which consist, on the one hand, of a dispersion medium and, on the other hand, of a dispersed phase.
- the dispersed phase generally comprises particles, in particular organic material, for example, cells or cell components.
- the dispersion medium can be understood as media which comprise the dispersed phase, dilute it, or receive it in another manner, for example, blood plasma.
- the analysis of the components of a dispersion can be carried out using optical methods, wherein a light beam, in particular a laser beam, is focused in the dispersion and subsequently examined for various optical features. In this manner, measured values for specific features of the dispersion can be ascertained.
- An analysis system is known from WO 00/58727, which consists of a light source, the light of which is focused in a dispersion circulation unit (flow cell) and is subsequently analyzed.
- the analysis relates in particular to the spectral ascertainment of the wavelengths of the light used which are absorbed in the dispersion.
- the diffraction characteristics in the near field and the far field are documented, to infer specific properties of the dispersion, in particular the particles contained in the dispersion, for example, the red blood cells, the white blood cells, or blood platelets.
- An optical, hematological examination as is known from the prior art, can advantageously be performed in an automated manner, wherein an array of optical features of the dispersion are examined.
- the optical analysis method limits the information content which is extractable for the dispersion. Although items of information can be obtained on the absorption behavior or frequency values of white and red blood cells or blood platelets, the extracted information content is still inadequate for carrying out many medical diagnoses.
- a blood sample of the patient cannot be automatically examined as a dispersion, but rather must be examined manually under the microscope in the laboratory.
- the present best method (the gold standard) for the malaria diagnosis is the blood smear on a slide or between two slides. Malaria parasites are detected by light microscopy by means of thin and thick blood smears. The accuracy of the diagnosis is dependent to a large extent on the quality of the blood smear and the experience of the laboratory personnel.
- a special ring shape which can be recognized under the microscope, is characteristic for red blood cells infected by parasites, however, a reliable diagnosis is only ensured if a sufficient number of these ring-shaped red blood cells can be counted in the dispersion of the blood sample.
- a physician can recognize whether it is a severe or less severe malaria infection.
- counting the ring-shaped red blood cells under the microscope is very boring, cumbersome, and subject to error, so that a malaria diagnosis is costly and excessively inaccurate.
- various laboratories refer in various notations to different ranges with respect to the counted ring-shaped red blood cells. In this manner, the question also arises of how a standardized, dependable malaria diagnosis or also diagnoses of other illnesses or negative states can be carried out reliably.
- the invention is based on the object of providing an optical analysis method, which improves the information content of an optical analysis method such that more precise statements are possible on the dispersion, in particular diagnoses and classifications.
- the analysis method for classification assistance includes the following steps:
- the classification index is provided for the purpose of giving information which enables a classification to be performed for a dispersion, in particular an organic dispersion.
- the classifications can originate in this case from various fields of medicine, technology, or from probability theory or from similar fields. Possible classifications are, for example, the presence or the absence of an illness, equally also the presence or the absence of a property, which is to be understood in the most general meaning. In this case, the number of classes is equally not restricted much, nor is the technical field thereof, thus, two, three, or multiple classification alternatives can be possible and can be indicated by the classification index.
- the classification by the classification index is to be considered to be a proposal, which is correct at a specific probability, but does not necessarily have to be present. It is therefore possible that the classification index proposes a classification of the dispersion, but this proposal does not apply with respect to the individual case at a specific, ideally low probability.
- a dispersion medium is understood as a medium, in particular a liquid medium, which is capable of receiving the dispersed phase such that the cells or cell components associated with the dispersed phase can also be transported by a movement of the dispersion medium.
- a test dispersion it is advantageous in the case of a test dispersion to be classified, for example, a blood sample, to keep it in a flowing state during the optical ascertainment of measured values for the optical features. In this manner, it is possible, on the one hand, to ensure thorough mixing of the test dispersion, which is required for statistical consideration, or alternatively to avoid intrinsically caused changes of the dispersion, for example, a coagulation in the event of blood dispersions.
- the classification index is dependent on a number of the optical features of the test dispersion.
- a measured value is to be assigned to an optical feature of the test dispersion, whereby a specific information content of the test dispersion can be inferred by the measurement of the assigned measured value.
- An optical feature can be, for example, a number of specific cells, for example red blood cells, white blood cells, or the like, within a specific volume unit. However, it can also be an optical feature on the shape or absorption characteristic of the mentioned cells. This feature list is not exhaustive.
- optical features per se do not enable an unambiguous classification, indexing, or diagnosis, so that a single optical feature hardly provides any valuable items of information.
- optical features nonetheless bear a certain significance per se with respect to a classification.
- technical backgrounds or technical prior knowledge can be used for the selection of the optical features, the measured values of which can then be used as the basis for the analysis method for the classification assistance.
- These fundamental optical features are also referred to hereafter as a feature set.
- the optical features are used which occur in conjunction with red blood cells. This can be established by prior knowledge, which originates from the conventional microscope-based diagnosis assistance, in which red blood cells are also examined.
- other optical features which relate to other components of the test dispersion can gradually be added to the feature set or features already associated with the feature set can be removed based on the significance of the information content.
- an optical feature although it relates to the red blood cells, has no informative power with regard to malaria and can therefore be removed from the feature set.
- an optical feature which relates to a cell for example, which interacts with the red blood cells, and therefore also plays a role in a parasitic malaria infestation, can contribute via the corresponding optical feature such that its significant information content is provided for the analysis method for classification assistance, in that the optical feature is taken into consideration for a malaria diagnosis assistance.
- a significance parameter is assigned in each case to an optical feature, wherein it can indicate by its absolute value and/or its sign to what extent the measured value of the respective optical feature has an effect on the classification index. Furthermore, a ranking can be established on the basis of the significance parameter, on the basis of which the importance of the feature for a classification, diagnosis, or the like is shown. On the basis of the significance parameter, it is also possible to recognize whether the measured value of an optical feature should advantageously still be used in the feature set for the analysis method for classification assistance.
- One goal of the analysis method for classification assistance is the most accurate possible determination of the significance parameters for the optical features to be identified as important.
- the classification index is dependent on mean values, wherein the individual mean values can each be assigned to optical features.
- the mean values are mean values of measured values of the respective optical feature which are obtained from calibration data.
- the classification index is dependent in particular on the difference of the ascertained measured value of the test dispersion and the mean value for the optical feature, whereby the ascertained measured value influences the classification index more strongly the more remote it is from the mean value.
- the classification index is dependent on the standard deviation of the respective optical feature, whereby a scaling is achieved which takes into consideration a natural variance of the measured value of the optical feature to be considered, and therefore the natural variance of the measured value cannot influence the classification index, wherein simultaneously no imbalance results between the summands of the sum in the classification index formula.
- the mean value of the optical feature and the standard deviation of the measured value of the optical feature have been ascertained on the basis of first calibration data, wherein the first calibration data are derived from dispersions having a negative classification, in particular are derived from the first and second calibration data, wherein the second calibration data are derived from dispersions having positive classification.
- first calibration data are derived from dispersions having a negative classification
- second calibration data are derived from dispersions having positive classification.
- only two classes are provided for the classification. For example, in an analysis method for classification assistance in illness diagnoses, a statement is simply required as to whether the test dispersion originates from a sick patient or from a healthy patient.
- the mean values of measured values of a specific optical feature are considered with regard thereto, with the previous knowledge of whether the test dispersion is to be assigned to a positive classification or a negative classification.
- the mean value can be formed using measured values of the optical feature in which a negative classification is known. In the case of illness diagnoses, this would correspond to a certain extent to a calibration using a mean value of healthy patients. Therefore, the deviation of the measured value of the test dispersion from this mean value is evaluated as the information content, which has relevance with regard to the classification. If the ascertained measured value of the test dispersion is very close to the mean value or is even identical thereto, the associated optical feature thus does not provide a contribution.
- the first calibration data can be derived from dispersions of negative classification, but also alternatively from dispersions having a positive classification.
- the second calibration data are therefore associated in each case with the classification different from that of the first calibration data.
- calibration data are ascertained from measured values of optical features measured on dispersions, which were ideally established with a large variety of dispersions, to ensure a statistical informative power which is required for optimum classification assistance.
- These calibration data can have been ascertained by means of classification methods of the prior art, for example in the case of malaria diagnosis, by means of blood smears and the microscopic evaluation thereof.
- the classification data should be based on a sufficient number of dispersions of different classifications, ideally an essentially equal number of data sets for the respective classification.
- the significance parameters are advantageously derived from the first and from the second calibration data by means of a discrimination analysis, wherein in particular a Bayesian theory is used in the discrimination analysis.
- the classification index is interpreted as a random variable, wherein a probability of the presence of a classification can be plotted over the frequency of the classification index.
- the classification index supplies a probability distribution, which contains both test dispersions having positive and also negative classification, or generally, using all provided classifications.
- the discrimination analysis describes how decisions, which result in an accurate classification, are to be made on the basis of the probability distribution over the classification index.
- a classification rule can be specified, on the basis of which value ranges of the classification index can be assigned to a specific classification.
- a threshold value can also be specified for the classification index, which divides the value range of the classification index into two intervals and therefore also results in a classification rule.
- the illness diagnosis if the value falls below the specified threshold value, a negative diagnosis can be proposed, and if the threshold is exceeded, a positive diagnosis can be proposed.
- the Bayesian theory can be used, wherein prior and posterior probability can also be incorporated into the calculation.
- prior and posterior probability can also be incorporated into the calculation.
- sufficient knowledge or calibration data of reliable prior probabilities has to be provided, so that the theory comes to bear.
- probabilities which are estimated with previous knowledge are considered to be prior probabilities and probabilities which were calculated afterwards are considered to be posterior probabilities.
- the distance of the focal points to the test data is to be taken into consideration.
- the mean value of the measured value of an optical feature is the arithmetic mean of multiple measured values of first and/or second calibration data.
- the mean value of a measured value for an optical feature can also be a focal point of a group of points in one-dimensional or multidimensional space.
- a threshold value is usable for the classification assistance, wherein a positive classification exists if the classification index is greater than the threshold value and a negative classification exists if the classification index is less than the threshold value.
- the threshold value can be selected as a function of the mean classification index, wherein the threshold value can be, for example, the arithmetic mean of the two mean classification indices.
- the threshold value can also be based on the variance of classification indices, which can vary more or less strongly as a function of the classification. Fundamentally, the ascertainment of the threshold value can take place on the basis of the discrimination analysis. For example, the threshold value can be established between the two mean classification indices such that positive and negative classification is equally probable at the threshold value.
- a positive classification indicates a presence of a deficiency, a parasitic infestation, or a nonnormal state, wherein the deficiency is in particular an anemia, in particular a Mediterranean anemia or a sickle-cell anemia, and wherein the parasitic infestation is in particular leishmaniasis or another parasitic infection.
- the mentioned presence of a deficiency, a parasitic infestation, or a nonnormal state can always be assigned to the test dispersion, so that a statement or diagnosis on the test dispersion is possible.
- a higher number n the number of the summands of the classification index Y also increases accordingly. A balance can always be made between computing effort and additional information content in the selection of the number.
- the feature set can be selected to be very small, i.e., only a few, ideally two optical features are sufficient to propose a classification reliably enough.
- the measured values of the optical features which are used for the calculation of the classification index are advantageously also relevant for the classification, wherein the classification index is formed from a sum, the number of the summands of which corresponds to the number of optical features used.
- the analysis beam advantageously extends essentially in a Z direction, which is perpendicular to both the X direction and also the Y direction.
- the analysis beam can have been focused, defocused, or conditioned in another manner, for example by optical lenses, optical filters or the like, to have an optimum beam diameter in the test dispersion.
- the analysis beam is analyzed, wherein, for example, near field scattering, far field scattering, and/or wavelength absorptions can be taken into consideration in the meaning of a spectral analysis.
- the invention furthermore includes an ascertainment method for determining analysis parameters of the analysis method according to the invention, wherein for an established number of optical features, the analysis parameters of the standard deviation, the mean value, and the significance parameter are ascertained based on the first and/or the second calibration data.
- the mean values for example, as focal points, are formed from measured values, which are obtained from calibration data, of the respective optical features. This applies accordingly to the associated standard deviations of the measured values obtained from the first and/or the second calibration data.
- At least the significance parameters have to be varied in the ascertainment method to optimize the classification assistance, in order to establish a weighting of the summands of the classification index such that a classification is as unambiguous as possible. This is precisely the case if value ranges of the classification index, which are each to be assigned to a classification, do not overlap with one another. A non-overlap will occur extraordinarily rarely in practice, but optimization is to be performed so that the mentioned value ranges overlap as little as possible.
- At least one control parameter in particular a measure of the overlap of the above-mentioned value ranges, is advantageously calculated based on the analysis parameters, in particular based on the significance parameters, to evaluate the classification assistance.
- the classification assistance is better the more the value ranges of different classifications are separated from one another, or the less they overlap.
- At least a part of the analysis parameters is adapted after an evaluation by a first control parameter, wherein in particular an adaptation of the at least one analysis parameter and the evaluation of the classification assistance are to be executable alternately until an improvement is no longer possible or is no longer desirable.
- the present first and second calibration data always result, upon the variation of the analysis parameters or a part of the analysis parameters, in a different probability distribution of the classification index of the mentioned calibration data.
- first and second calibration data are to demonstrably result in separable probability density distributions of different classifications.
- the first control parameter could be, for example, a minimum between the mentioned distributions, wherein the first control parameter always becomes smaller as much as possible during the progressive adaptation of the analysis parameters or the part thereof, so that a separation of the two distributions results more and more clearly.
- Other first control parameters can also be selected, which are ascertained, for example, by separate curve fits of the mentioned probability distributions. Multiple first control parameters can also play a role in this case, wherein they are obtained from the fit parameters, or are simply identical to one or more of the fit parameters.
- the at least one part of the analysis parameters are/is advantageously the significance parameters and/or the threshold value.
- the part of the analysis parameters to be adapted does not have to be identical to one type of analysis parameters, for example significance parameters, standard deviation, or mean value, but rather can also include parameters of different types.
- the threshold value can also be adapted to the probability distribution of the classification index, if distribution functions stand out for the distributions of different classifications, which can have effects on the threshold value.
- the ascertainment method or the analysis method is executable again using a reduced number of optical features as soon as an improvement is no longer possible, or is no longer desired, in consideration of the first control parameter, wherein the analysis parameters of one nonsignificant optical feature or multiple nonsignificant optical features are no longer taken into consideration, wherein a lack of significance of an optical feature is determined on the basis of the respective significance parameter. Since it is usually not known beforehand which measured values of optical features could actually contribute to the informative power of the classification index, for example, a large number of measured values of optical features can be taken into consideration at the beginning—ideally all available measured values, wherein measured values of optical features can gradually be excluded by the ascertainment method, because they have no or only a very small contribution to the informative power of the classification index.
- the significance parameter is decisive in this case, which indicates a significance if it is clearly not equal to zero.
- a lack of significance preferably exists if the influence of the optical feature on the classification index is small or does not exist. Nonetheless, measured values of various optical features can be omitted, if measured values of other optical features have sufficient information content. In this case, it is conceivable, for example, to begin with one feature set, which is comparatively small, and successively to add further measured values of other optical features to the feature set, whereby it can be tested in the individual case as to whether an improvement of the classification assistance has been achieved.
- the subject matter of the invention is a computer program product, which makes a computer capable of executing the analysis method according to the invention and/or the ascertainment method according to the invention.
- the first and/or second calibration data are provided to the computer in a suitable manner as data sets, so that the analysis parameters can be ascertained on a computer-implemented basis. It is advantageous in particular if comparative data exist, which were not used for the calibration, but on the basis of which the analysis method can be tested for its classification assistance.
- the computer program product in particular compact disks or the like, can advantageously contain an installable algorithm.
- the algorithm executes program loops having corresponding abort condition, which both can be used for ascertaining analysis parameters and also can be used for eliminating analysis parameters.
- the subject matter of the invention is also an optical analysis system, in particular a hematological analysis system, having an analysis unit for carrying out an optical measured value recording of measured values, which can be assigned to optical features of the test dispersion.
- optical analysis systems represent, for example, hematological analysis devices, which automatically ascertain an entire array of various measured values, which are assignable to optical features.
- the number of automatically ascertained measured values can be from several hundred up into the thousands, for example 1000 or 2000.
- FIG. 1 shows an optical analysis system according to the prior art
- FIG. 2 shows a schematic illustration of a part of the data flow according to the analysis method according to the invention
- FIG. 3 shows an illustration of significance parameters for the associated measured value of a respective feature, ordered according to the absolute value thereof
- FIG. 4 shows a schematic diagram for the ascertainment of analysis parameters and a quality test for the analysis method
- FIG. 5 shows a schematic illustration of program loops to improve the classification assistance
- FIG. 6 shows two graphic representations for use in the discrimination analysis
- FIG. 7 shows a two-dimensional graphic illustration of the control and improvement of the classification assistance
- FIG. 8 shows a graphic illustration of a specificity histogram
- FIG. 9 shows an illustration of a sensitivity histogram.
- FIG. 1 shows an optical analysis system 10 , which generates, using a light source 1 , for example a laser, an analysis beam 13 , which is focused in various lenses 2 such that the analysis beam 13 has a focus in an organic dispersion 12 , wherein subsequently further focusing of the beam is performed by further lenses 2 , so that it is analyzable in a large area by way of a beam splitter 3 , on the one hand, in a spectral sensor 7 , for example a spectrometer, and far field diffraction pattern 5 and near field diffraction pattern 6 are each detectable in a sensor via the mirror 4 . In this manner, an entire array of measured values, which is to be assigned to an optical feature of the organic dispersion 12 , may be determined automatically.
- a light source 1 for example a laser
- an analysis beam 13 which is focused in various lenses 2 such that the analysis beam 13 has a focus in an organic dispersion 12 , wherein subsequently further focusing of the beam is performed by further lenses 2
- the measured values P 1 to P 29 from the optical analysis method are processed in downstream data processing 8 , which can be performed in a computer, for example, so that the measured values P 1 are usable in a multivariate analysis.
- the multivariate analysis consists of executing an exemplary embodiment of an analysis method according to the invention and determining a classification index Y, which can be assigned to the organic dispersion 12 from FIG. 1 .
- the classification index Y can be output in this case, for example, together with a threshold value Y S , so that it is apparent for the operator of the optical analysis system 10 how a classification can be performed.
- this relates not only to a classification assistance in this case, in which a classification proposal is output by the analysis method.
- FIG. 3 shows a diagram having significance parameters l i , wherein the significance parameters l i have been plotted over the respective measured value P i .
- the measured values P i receive the running number i as a function of the absolute value of the associated significance parameter l i .
- the sequence which is provided by the counter i also simultaneously reflects information about the information contribution of the measured value to the classification index.
- the diagram shown in FIG. 3 relates to the same measured values P i which are also shown in FIG. 2 .
- FIG. 4 shows the example of a classification assistance for the malaria diagnosis, in which the analysis parameters are to be found by checking the quality of the classification assistance.
- the malaria diagnosis assistance 20 is based on a training phase 28 and a subsequent test phase 31 .
- the test phase 31 enables the standardization 27 of the training phase 28 .
- the training 22 is begun on the basis of a value allocation 25 for the analysis parameters Y s , E i , l i , ⁇ i , wherein a probability distribution of the classification index is generated on the basis of calibration data and a scaling is performed on the basis of this probability distribution, which enables a threshold Y s to be specified. If the scaling 29 was successful, the value allocation of the analysis parameters Y s , E i , l i , ⁇ i is thus retained, to be used in the analysis method.
- test data which preferably are not part of the calibration data, but rather have been taken from another data set or another examination or the like.
- the classification 32 is the classification which can be assigned to the analysis method.
- the sensitivity and specificity are observed, to establish the classification accuracy, or in the case of a malaria classification assistance, the diagnosis accuracy, respectively.
- the specificity is defined as the probability of a negative diagnosis, supposing that this classification is correct.
- Sensitivity is defined as the probability of a positive classification, supposing that this classification is correct.
- the correctness is established in the case of sensitivity and also in the case of sensitivity using the calibration data in a comparison.
- the analysis method can offer an efficient classification rule, which meets the quality standards of medical analysis systems.
- FIG. 5 shows which steps of the steps known from FIG. 4 are to be reproduced.
- the processing sequence 50 having the steps of resampling 21 , training 22 , prediction 23 , and the quality control 24 can be repeated several hundred times, also thousands of times, typically precisely 1000 times, if personal computers are used.
- the inner loop terminates with the processing sequence 50 .
- the inner loop can propose a classification rule upon each execution. This is accordingly true upon the execution of the outer loop 52 .
- a query 51 is then performed as to whether a significance parameter l i is sufficiently small that it cannot contribute usable information to the classification index. If such a significance parameter l i is found, all analysis parameters which are associated with the respective optical measured value are thus not considered further, these include the standard deviation ⁇ i , the mean value E i , and the significance parameter l i of the irrelevant optical feature.
- the significance parameter which can be l 28 , for example, could thus have assumed a value which is very close to zero. Therefore, the number of fragments is subsequently no longer used for the malaria diagnosis, in that the standard deviation ⁇ 28 , the mean value E 28 , and the significance parameter l 28 are no longer taken into consideration.
- FIG. 6 shows two diagrams, wherein, in the upper diagram, the frequency of classification indices Y for a negative classification (narrow bars) and a positive classification (wide bars) are plotted over the classification index Y. It is apparent from the upper diagram that significantly fewer data sets are available for the positive classification than for a negative classification.
- the two distributions of different classifications were considered as a probability density distribution, and scaled accordingly therefrom.
- This scaling can set the surface area of the respective distributions to one, for example. Other scalings are possibly also advantageous.
- the scalings ensure that the different number of classifications in the calibration data does not have any influence on the classification rule to be determined.
- a threshold Y s would be determinable very easily, specifically in that Y s would be established between the value ranges of the two distributions.
- Y s would be established between the value ranges of the two distributions.
- the malaria diagnosis it behaves so that the probability of an incorrect classification is possible for a range around the established threshold Y s , because the classification index Y only has inadequate informative power in this range. The closer the classification index Y at a test dispersion is to the threshold value Y s , the more probable is an incorrect classification.
- a discrimination analysis of the distributions provided in FIG. 6 results in an establishment of the analysis parameters as specified in the following table for the analysis method for malaria diagnosis assistance.
- the number of the summands for determining the classification index is 29 and is identical to the number of optical features to be considered, which actually play a role in the test of the test dispersion. In fact, it began with 500 optical features, wherein 471 thereof proved to have a very small significance parameter l i in the course of the application of the ascertainment method and were removed from the set of the features i to be considered.
- the analysis parameters l i , E i , ⁇ i of the remaining 29 optical features i read:
- a diagnosis proposal can therefore be provided for each ascertained classification index of a blood sample with a small residual risk, namely with Y>1.822 a positive malaria finding and with Y ⁇ 1.822 a negative malaria finding.
- the specificity distribution 41 and the sensitivity distribution 40 were ascertained and plotted against one another in a two-dimensional graph. If the distributions are divided into 4 equal parts, the two middle quarters can thus be taken into consideration for this observation. In other words, the IQR 42 (interquartile range) of the distribution 40 and the IQR 43 of the distribution 41 are taken into consideration. To achieve the best results, it is recommended that classification rules be selected which are established within the intersection range S shown, to meet the highest medical requirements.
- the sensitivity reaches 96.25%, and upon an observation of the IQR, it reaches a range from 59% to 97.5%.
- the specificity reaches an average of 98.29% and upon an observation of the IQR reaches a range from 97.98% to 89.60%.
- a correct classification is therefore extremely probable, wherein incorrect classification proposals can be excluded with only a small residual risk.
- FIG. 8 and FIG. 9 each show the number of established specificities or sensitivities in the form of histograms.
- the specificity S p and the sensitivity S E were already used as the bar diagram in FIG. 7 .
- the invention relates to an analysis method for classification assistance, an ascertainment method for determining analysis parameters Y S , E i , l i , ⁇ i for the analysis method, a computer program product, and an optical analysis system for classification assistance, in which, based on first and second calibration data, analysis parameters Y S , E i , l i , ⁇ i can be established, which provide a classification assistance according to rules of discrimination analysis, which, on the basis of measured values P i of optical features i, in particular organic dispersions, enable the information content thereof for the classification, in particular illness diagnoses, a classification proposal or diagnosis proposal in comparison to a threshold Y S .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Ecology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
-
- ascertaining measured values (Pi) for optical features of a test dispersion to be classified, wherein the test dispersion is formed from a dispersion medium, in particular blood plasma, and a dispersed phase and the dispersed phase has cells or cell components, in particular organic materials,
- calculating a classification index Y, defined by:
wherein the classification index Y is dependent on a number n of the optical features i of the test dispersion, a significance parameter li of the respective optical feature i, a mean value Ei of the respective optical feature i, and a standard deviation σi of the respective optical feature i.
Y(n=2)=l 1*(P 1 −E 1)/σ1 +l 2*(P 2 −E 2)/σ2,
wherein n=2 and a first optical feature is a measure of optical scattering in a transverse X direction in relation to an analysis beam and a second optical feature is a measure of optical scattering in a Y direction, which is perpendicular to the X direction and also perpendicular to the analysis beam, wherein the analysis beam extends through the test dispersion. With a higher number n, the number of the summands of the classification index Y also increases accordingly. A balance can always be made between computing effort and additional information content in the selection of the number.
TABLE 1 | |||
i | li | Ei | σi |
1 | 0.0243143292327641 | 3.85878279704797 | 0.996350482855477 |
2 | 1.05744699221905 | 86.2085734326568 | 12.953846866348 |
3 | 1.3620780210087 | 31.3808859769373 | 2.65337438754902 |
4 | 0.298681341952128 | 16.7073148570111 | 3.05622820486547 |
5 | 0.039685909568696 | 3.18916825922509 | 0.610392795099183 |
6 | 0.802606052864478 | 22.4169387250923 | 6.67725822054997 |
7 | 0.013290099049454 | 1.80846317896679 | 0.490486418856065 |
8 | 0.172647099054505 | 0.602234248154981 | 0.216930342394397 |
9 | 0.0796067332070757 | 7.38290569464945 | 11.6539118822964 |
10 | 0.197381907473051 | 4.55739805811808 | 10.0180223771838 |
11 | 0.399165319578081 | 19.4079367287823 | 22.1428759582116 |
12 | 0.0494342161138479 | 1.24748103597786 | 2.31647351118736 |
13 | 1.44026210168956 | 26.9894740940959 | 5.0938073590873 |
14 | 0.520893299030793 | 4.28650641605166 | 1.07368357499902 |
15 | 0.284413335456635 | 16.4872902721402 | 12.5135939166568 |
16 | 0.531892835621228 | 7.23708487084871 | 8.95211789259242 |
17 | 0.698987246767777 | 336.37508399262 | 233.481906156752 |
18 | 0.488427163694765 | 9.19492226291513 | 2.00576799720274 |
19 | 0.683216666590792 | 53.4022117638376 | 11.7120398800053 |
20 | 2.39463588229883 | 23.307653449262 | 2.81445425488391 |
21 | 0.493291518472633 | 5.742889099631 | 0.731852460724153 |
22 | 0.199742256744743 | 1.95712033394834 | 0.25494636006376 |
23 | 1.76951528599063 | 0.839687189114391 | 0.161239146887579 |
24 | 0.0918169689792613 | 1.37246023431734 | 0.00515681120954237 |
25 | 2.99867547853134 | 34.8957316577491 | 5.81915230603462 |
26 | 2.46145277256995 | 17.5466706845018 | 3.58836148561811 |
27 | 0.0213275666681148 | 8.33807254059041 | 7.74938961818539 |
28 | 0.477404018065088 | 0.0352406872693727 | 0.136793871627217 |
29 | 0272433630134861 | 0.016729979704797 | 0.0197033898754757 |
The above table lists the analysis parameters li, Ei, σi, wherein both the associated measured value Pi and also the listed analysis parameters li, Ei, σi are assigned to the respective optical feature i, and wherein the parameter i is to be understood as the number of the respective optical feature. |
TABLE 2 | |||
ADVIA | |||
parameter/optical | Definition of the measured value | ||
i | Pi | feature | Pi for the respective feature i |
1 | P1 | RBC | Count of the red blood cells from |
the RBC/PLT channel | |||
2 | P2 | MCV | Mean cell volume of the counted |
red blood cells (RBC) | |||
3 | P3 | CHCM | Mean hemoglobin concentration |
(g/dL) of the cells (from RBC) | |||
4 | P4 | RDW | Density distribution breadth of |
the red blood cells (from RBC) | |||
5 | P5 | HDW | Breadth of the hemoglobin density |
distribution (g/dL) | |||
6 | P6 | plat_mode | PLT mode |
7 | P7 | mu_fit | μ-FIT |
8 | P8 | sig_fit | σ-FIT |
9 | P9 | micro_pcnt | Number of the RBC cells in percent |
having fewer than 60 fL | |||
10 | P10 | macro_pcnt | Number of the RBC cells in percent |
having more than 120 fL | |||
11 | P11 | hypo_pcnt | Number of the red blood cells in |
percent having a hemoglobin | |||
concentration of less than 28 g/dL | |||
12 | P12 | hyper_pcnt | Number of the red blood cells in |
percent having a hemoglobin | |||
concentration of less than 41 g/dL | |||
13 | P13 | H_mean | Mean value of the hemoglobin |
concentration in picograms | |||
14 | P14 | H_deviation | Breadth of the hemoglobin content |
distribution in picograms | |||
15 | P15 | VHC_covar | Covariance of the hemoglobin density |
distribution | |||
16 | P16 | MN_PMN_valley | The BASO MN/PMN minimum as a |
depression between the MN and PMN | |||
clusters of the BASO cytogram | |||
17 | P17 | PLT | Count of the recognized blood |
platelets | |||
18 | P18 | MPV | Mean blood platelet volume |
19 | P19 | PDW | Blood platelet distribution breadth |
20 | P20 | MPC | Mean blood platelet component |
concentration | |||
21 | P21 | PCDW | Distribution breadth of the blood |
platelet component concentration | |||
22 | P22 | MPM | Mean blood platelet dry mass |
23 | P23 | PMDW | Distribution depth of the blood |
platelet dry mass | |||
24 | P24 | PLT_Mean_n | Mean of a refractive index of the |
blood platelets (from PLT | |||
measurement) | |||
25 | P25 | PLT_Mean_X | Mean value of the diffraction |
deflection in X direction | |||
26 | P26 | PLT_Mean_Y | Mean value of the diffraction |
deflection in Y direction | |||
27 | P27 | Large_PLT | Large blood platelets (number) |
28 | P28 | RBC_Fragments | Number of the counted fragments in |
the PLT diffraction cytogram | |||
29 | P29 | RBC_Ghosts | Number of the events in the PLT |
diffraction cytogram without | |||
assignment | |||
ADVIA is a hematological analysis system having automated measured value ascertainment. The measured values Pi are indicated with the respective abbreviation thereof, as are used in the so-called ADVIA export files, and are defined in the last column. |
Claims (19)
Y(n=2)=l 1*(P 1 −E 1)/σ1 +l 2*(P 2 −E 2)/σ2,
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102013216362 | 2013-08-19 | ||
DE102013216362.2 | 2013-08-19 | ||
DE102013216362.2A DE102013216362A1 (en) | 2013-08-19 | 2013-08-19 | Analysis method for classification support |
PCT/EP2014/066786 WO2015024770A1 (en) | 2013-08-19 | 2014-08-05 | Analysis method for supporting classification |
Publications (2)
Publication Number | Publication Date |
---|---|
US20160202171A1 US20160202171A1 (en) | 2016-07-14 |
US10401275B2 true US10401275B2 (en) | 2019-09-03 |
Family
ID=51357909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/912,876 Active 2035-03-10 US10401275B2 (en) | 2013-08-19 | 2014-08-05 | Analysis method for supporting classification |
Country Status (6)
Country | Link |
---|---|
US (1) | US10401275B2 (en) |
EP (1) | EP2997365B1 (en) |
JP (1) | JP6611716B2 (en) |
CN (1) | CN105474013B (en) |
DE (1) | DE102013216362A1 (en) |
WO (1) | WO2015024770A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11521115B2 (en) | 2019-05-28 | 2022-12-06 | Microsoft Technology Licensing, Llc | Method and system of detecting data imbalance in a dataset used in machine-learning |
US11526701B2 (en) * | 2019-05-28 | 2022-12-13 | Microsoft Technology Licensing, Llc | Method and system of performing data imbalance detection and correction in training a machine-learning model |
US11537941B2 (en) | 2019-05-28 | 2022-12-27 | Microsoft Technology Licensing, Llc | Remote validation of machine-learning models for data imbalance |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3076333A1 (en) * | 2015-04-02 | 2016-10-05 | Siemens Aktiengesellschaft | Analysis method for classification of a test dispersion to determine the presence of sickle cell anaemia |
WO2017046799A1 (en) | 2015-09-17 | 2017-03-23 | S.D. Sight Diagnostics Ltd | Methods and apparatus for detecting an entity in a bodily sample |
US11307196B2 (en) | 2016-05-11 | 2022-04-19 | S.D. Sight Diagnostics Ltd. | Sample carrier for optical measurements |
JP7214729B2 (en) | 2017-11-14 | 2023-01-30 | エス.ディー.サイト ダイアグノスティクス リミテッド | Sample container for optical measurement |
WO2019240876A1 (en) * | 2018-06-15 | 2019-12-19 | Beckman Coulter, Inc. | Method of determining sepsis in the presence of blast flagging |
DE102019114117B3 (en) * | 2019-05-27 | 2020-08-20 | Carl Zeiss Microscopy Gmbh | Automatic workflows based on recognition of calibration samples |
CN111024569B (en) * | 2019-10-18 | 2022-07-01 | 重庆邮电大学 | Calibration method of abrasive particle detection sensor and storage medium thereof |
CN110823938A (en) * | 2019-11-14 | 2020-02-21 | 南京钢铁股份有限公司 | Method for statistical analysis of TiN and TiC inclusions in steel material |
CN111401407B (en) * | 2020-02-25 | 2021-05-14 | 浙江工业大学 | Countermeasure sample defense method based on feature remapping and application |
Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737109A1 (en) | 1996-08-30 | 1998-03-12 | Pe Diagnostik Gmbh | Procedure for determining significant deviations in cell growth |
WO2000058727A1 (en) | 1999-03-31 | 2000-10-05 | Bayer Corporation | Single channel, single dilution detection method |
CN1371660A (en) | 2001-02-22 | 2002-10-02 | 上海市脑血管病防治研究所 | Method for evaluating apoplexy dangerous posibility by cerebrovascular hemodynamics parameter |
US20030017481A1 (en) | 1999-04-09 | 2003-01-23 | Whitehead Institute For Biomedical Research | Methods for classifying samples and ascertaining previously unknown classes |
DE10317717A1 (en) | 2003-04-17 | 2004-11-11 | Pe Diagnostik Gmbh | Dichotomous classification of measurements of disease markers, useful particularly for improved diagnosis of lung cancer, using a set of classifiers |
CN1653480A (en) | 2002-05-14 | 2005-08-10 | 维森盖特有限公司 | Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease |
JP2006501528A (en) | 2001-12-03 | 2006-01-12 | ディーエヌエー・プリント・ジェノミックス・インコーポレイテッド | Method and apparatus for combined genetic classification based on correspondence analysis and linear / quadratic curve analysis |
US20070231206A1 (en) * | 2006-03-30 | 2007-10-04 | Sysmex Corporation | Sample measuring apparatus and sample measuring method |
CN101059431A (en) | 2007-05-11 | 2007-10-24 | 上海师范大学 | Fusarium fungus infrared fingerprint quick identification method |
US20080186490A1 (en) * | 2007-02-02 | 2008-08-07 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Irradiation unit for a flow-cytometry-based analytical instrument and analytical instrument including the same |
WO2009136570A1 (en) | 2008-05-09 | 2009-11-12 | シスメックス株式会社 | Blood analyzer, blood analysis method and hemolytic agent |
CN101716069A (en) | 2009-11-17 | 2010-06-02 | 中国科学院安徽光学精密机械研究所 | Human body oxidative stress non-invasive fluorescence detection device and method |
US20100248247A1 (en) * | 2009-03-31 | 2010-09-30 | Sysmex Corporation | Blood analyzer and method for determining existence and nonexistence of lymphoblasts in blood sample |
US20100273168A1 (en) | 2009-04-27 | 2010-10-28 | Martin Krockenberger | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
US20110172514A1 (en) | 2008-09-29 | 2011-07-14 | Koninklijke Philips Electronics N.V. | Method for increasing the robustness of computer-aided diagnosis to image processing uncertainties |
US20110178716A1 (en) | 2010-01-15 | 2011-07-21 | Martin Krockenberger | Method for determining volume and hemoglobin content of individual red blood cells |
US20110306849A1 (en) * | 2009-02-26 | 2011-12-15 | Centre Hospitalier Universitaire D'angers | Diagnosis of Liver Fibrosis and Cirrhosis |
US20120115159A1 (en) * | 2009-07-03 | 2012-05-10 | Sysmex Corporation | Blood analyzer and blood analyzing method |
US20120282601A1 (en) * | 2011-05-05 | 2012-11-08 | Masaki Abe | Blood analyzer, blood analysis method, and computer program product |
WO2013093913A1 (en) | 2011-12-19 | 2013-06-27 | Opticul Diagnostics Ltd. | Spectroscopic means and methods for identifying microorganisms in culture |
US20130337496A1 (en) * | 2010-12-23 | 2013-12-19 | Siemens Aktiengesellschaft | Method for Detecting a Plasmodium Infection |
US20140011232A1 (en) * | 2012-07-05 | 2014-01-09 | Beckman Coulter, Inc. | Method and apparatus for determining white blood cell counts |
US20140051071A1 (en) * | 2011-04-28 | 2014-02-20 | Sysmex Corporation | Blood analyzer, blood analysis method, and computer program product |
-
2013
- 2013-08-19 DE DE102013216362.2A patent/DE102013216362A1/en not_active Ceased
-
2014
- 2014-08-05 US US14/912,876 patent/US10401275B2/en active Active
- 2014-08-05 WO PCT/EP2014/066786 patent/WO2015024770A1/en active Application Filing
- 2014-08-05 JP JP2016535396A patent/JP6611716B2/en active Active
- 2014-08-05 CN CN201480045769.3A patent/CN105474013B/en active Active
- 2014-08-05 EP EP14752580.2A patent/EP2997365B1/en active Active
Patent Citations (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737109A1 (en) | 1996-08-30 | 1998-03-12 | Pe Diagnostik Gmbh | Procedure for determining significant deviations in cell growth |
WO2000058727A1 (en) | 1999-03-31 | 2000-10-05 | Bayer Corporation | Single channel, single dilution detection method |
US20030017481A1 (en) | 1999-04-09 | 2003-01-23 | Whitehead Institute For Biomedical Research | Methods for classifying samples and ascertaining previously unknown classes |
CN1371660A (en) | 2001-02-22 | 2002-10-02 | 上海市脑血管病防治研究所 | Method for evaluating apoplexy dangerous posibility by cerebrovascular hemodynamics parameter |
JP2006501528A (en) | 2001-12-03 | 2006-01-12 | ディーエヌエー・プリント・ジェノミックス・インコーポレイテッド | Method and apparatus for combined genetic classification based on correspondence analysis and linear / quadratic curve analysis |
CN1653480A (en) | 2002-05-14 | 2005-08-10 | 维森盖特有限公司 | Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease |
DE10317717A1 (en) | 2003-04-17 | 2004-11-11 | Pe Diagnostik Gmbh | Dichotomous classification of measurements of disease markers, useful particularly for improved diagnosis of lung cancer, using a set of classifiers |
US20070231206A1 (en) * | 2006-03-30 | 2007-10-04 | Sysmex Corporation | Sample measuring apparatus and sample measuring method |
US20120244573A1 (en) * | 2006-03-30 | 2012-09-27 | Sysmex Corporation | Sample measuring apparatus and sample measuring method |
US20120164684A1 (en) * | 2006-03-30 | 2012-06-28 | Sysmex Corporation | Sample measuring apparatus and sample measuring method |
US20080186490A1 (en) * | 2007-02-02 | 2008-08-07 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Irradiation unit for a flow-cytometry-based analytical instrument and analytical instrument including the same |
CN101059431A (en) | 2007-05-11 | 2007-10-24 | 上海师范大学 | Fusarium fungus infrared fingerprint quick identification method |
EP2280278A1 (en) | 2008-05-09 | 2011-02-02 | Sysmex Corporation | Blood analyzer, blood analysis method and hemolytic agent |
WO2009136570A1 (en) | 2008-05-09 | 2009-11-12 | シスメックス株式会社 | Blood analyzer, blood analysis method and hemolytic agent |
US20110172514A1 (en) | 2008-09-29 | 2011-07-14 | Koninklijke Philips Electronics N.V. | Method for increasing the robustness of computer-aided diagnosis to image processing uncertainties |
US20110306849A1 (en) * | 2009-02-26 | 2011-12-15 | Centre Hospitalier Universitaire D'angers | Diagnosis of Liver Fibrosis and Cirrhosis |
US20100248247A1 (en) * | 2009-03-31 | 2010-09-30 | Sysmex Corporation | Blood analyzer and method for determining existence and nonexistence of lymphoblasts in blood sample |
JP2012525589A (en) | 2009-04-27 | 2012-10-22 | アボット・ラボラトリーズ | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
US20100273168A1 (en) | 2009-04-27 | 2010-10-28 | Martin Krockenberger | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
US20120115159A1 (en) * | 2009-07-03 | 2012-05-10 | Sysmex Corporation | Blood analyzer and blood analyzing method |
CN101716069A (en) | 2009-11-17 | 2010-06-02 | 中国科学院安徽光学精密机械研究所 | Human body oxidative stress non-invasive fluorescence detection device and method |
US20110178716A1 (en) | 2010-01-15 | 2011-07-21 | Martin Krockenberger | Method for determining volume and hemoglobin content of individual red blood cells |
CN102933964A (en) | 2010-01-15 | 2013-02-13 | 雅培制药有限公司 | Method for determining volume and hemoglobin content of individual red blood cells |
US20130337496A1 (en) * | 2010-12-23 | 2013-12-19 | Siemens Aktiengesellschaft | Method for Detecting a Plasmodium Infection |
US20140051071A1 (en) * | 2011-04-28 | 2014-02-20 | Sysmex Corporation | Blood analyzer, blood analysis method, and computer program product |
US20160202170A1 (en) * | 2011-04-28 | 2016-07-14 | Sysmex Corporation | Blood analyzer, blood analysis method, and computer program product |
US20120282601A1 (en) * | 2011-05-05 | 2012-11-08 | Masaki Abe | Blood analyzer, blood analysis method, and computer program product |
WO2013093913A1 (en) | 2011-12-19 | 2013-06-27 | Opticul Diagnostics Ltd. | Spectroscopic means and methods for identifying microorganisms in culture |
US20140011232A1 (en) * | 2012-07-05 | 2014-01-09 | Beckman Coulter, Inc. | Method and apparatus for determining white blood cell counts |
Non-Patent Citations (2)
Title |
---|
Chinese Search Report of Chinese Application No. 2014800457693 dated Nov. 14, 2017. |
Japanese Office Action of Japanese Application No. 2016-535396 dated Apr. 3, 2018. |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11521115B2 (en) | 2019-05-28 | 2022-12-06 | Microsoft Technology Licensing, Llc | Method and system of detecting data imbalance in a dataset used in machine-learning |
US11526701B2 (en) * | 2019-05-28 | 2022-12-13 | Microsoft Technology Licensing, Llc | Method and system of performing data imbalance detection and correction in training a machine-learning model |
US11537941B2 (en) | 2019-05-28 | 2022-12-27 | Microsoft Technology Licensing, Llc | Remote validation of machine-learning models for data imbalance |
Also Published As
Publication number | Publication date |
---|---|
DE102013216362A1 (en) | 2015-02-19 |
US20160202171A1 (en) | 2016-07-14 |
JP6611716B2 (en) | 2019-11-27 |
CN105474013A (en) | 2016-04-06 |
EP2997365A1 (en) | 2016-03-23 |
CN105474013B (en) | 2018-09-18 |
WO2015024770A1 (en) | 2015-02-26 |
EP2997365B1 (en) | 2018-05-23 |
JP2016528506A (en) | 2016-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10401275B2 (en) | Analysis method for supporting classification | |
US8837803B2 (en) | Method and apparatus for determining mean cell volume of red blood cells | |
JP4354977B2 (en) | A method for identifying discrete populations (eg, clusters) of data in a flow cytometer multidimensional dataset | |
JP7286863B2 (en) | Automated validation of medical data | |
JP5530691B2 (en) | Blood cell counter, diagnosis support apparatus, diagnosis support method, and computer program | |
Delanghe | New screening diagnostic techniques in urinalysis | |
WO2023186051A1 (en) | Auxiliary diagnosis method and apparatus, and construction apparatus, analysis apparatus and related product | |
CN115691722A (en) | Quality control method, apparatus, device, medium and program product for medical data detection | |
CN105372235B (en) | Urine sample evaluation method, analysis device, and analysis system | |
Larsson et al. | Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument | |
EP3978902A1 (en) | Maturity classification of stained reticulocytes using optical microscopy | |
Cobbaert et al. | Automated urinalysis combining physicochemical analysis, on-board centrifugation, and digital imaging in one system: a multicenter performance evaluation of the cobas 6500 urine work area | |
Chen et al. | Automatic whole blood cell analysis from blood smear using label-free multi-modal imaging with deep neural networks | |
JP5314145B2 (en) | Method and apparatus for classification, visualization and search of biological data | |
Topcu | How to explain a machine learning model: HbA1c classification example | |
US20230066255A1 (en) | Medical analysis device with impedance signal processing | |
Majors et al. | Evaluation of the LeukoScope for Point-of-Care Measurement of White Blood Cell and Neutrophil Counts in Malawi | |
Okandeji et al. | A comparative analysis of haemoglobin variants using machine learning algorithms | |
EP4293342A1 (en) | Automatic analyzer and method for optically analyzing a biological sample | |
Farih et al. | Research Journal of Surgery | |
Farih et al. | Research Journal of Applied Medical Sciences | |
EP4367669A2 (en) | All-electronic analysis of biochemical samples | |
Neelakantan et al. | Analyzing white blood cells using deep learning techniques | |
Kavthekar | Computational Quantification of Renal Tubular Morphology in Digitized Biopsies and Application in Diabetic Nephropathy | |
Hassan et al. | Uncertenity Evaluation of boold analyser system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SIEMENS AKTIENGESELLSCHAFT OSTERREICH, AUSTRIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KAVSEK, BARBARA;LEDERER, PETER;REEL/FRAME:041374/0057 Effective date: 20160818 Owner name: SIEMENS HEALTHCARE NEDERLAND B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAAL, PETER;BOOGAART, JAN VAN DEN;REEL/FRAME:041374/0272 Effective date: 20160919 Owner name: SIEMENS HEALTHCARE DIAGNOSTIC PRODUCTS GMBH, GERMA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SIEMENS HEALTHCARE NEDERLAND B.V.;REEL/FRAME:041374/0505 Effective date: 20160919 Owner name: SIEMENS AKTIENGESELLSCHAFT, BERLIN AND MUNICH, GER Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SIEMENS AKTIENGESELLSCHAFT OSTERREICH;REEL/FRAME:041374/0652 Effective date: 20160824 Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, GERM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SIEMENS AKTIENGESELLSCHAFT, BERLIN AND MUNICH;REEL/FRAME:041374/0788 Effective date: 20160824 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |